Quesada-Jimenez Roger, Walsh Elizabeth G, Keane Jessica C, Kahana-Rojkind Ady H, Domb Elijah S, Domb Benjamin G
American Hip Institute Research Foundation, Chicago, Illinois.
American Hip Institute, Chicago, Illinois.
J Bone Joint Surg Am. 2025 May 21;107(13):1461-1471. doi: 10.2106/JBJS.24.01054.
Depression and anxiety are recognized as adverse prognostic factors in various orthopaedic surgical interventions. The aim of this study is to report the intermediate-term outcomes of hip arthroscopy for the treatment of femoroacetabular impingement (FAI) and labral tears in patients with depression and/or anxiety.
Data were retrospectively analyzed for patients with a self-reported history of depression and/or anxiety who had undergone primary hip arthroscopy for the treatment of FAI and labral tears from 2008 to 2018. Included patients had at least 1 of the following patient-reported outcome (PRO) scores: the modified Harris hip score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score-Sports-Specific Subscale (HOS-SSS), International Hip Outcome Tool (iHOT-12), patient satisfaction, Short Form 12-Mental (SF-M), Veterans RAND 12 Item-Mental (VR-M), and visual analog scale (VAS) for pain, or a revision procedure during the study period. Patients were propensity-matched with a benchmark control group of patients without depression and/or anxiety, in a 1:1 ratio, to control for confounding variables. Clinically relevant thresholds, revision procedures, and survivorship rates were also included in the analysis.
One hundred and twenty-five hips in patients with depression and/or anxiety were included in the study and were successfully matched to 125 control hips in patients without depression and/or anxiety. The depression/anxiety cohort demonstrated significant improvement in all functional outcome scores, with a magnitude of improvement that was comparable with that in the control group. However, the depression/anxiety group started with significantly lower preoperative scores for the HOS-SSS, SF-M, and VR-M; ended with lower intermediate-term scores for the mHHS, NAHS, HOS-SSS, SF-M, and VR-M; and had lower rates of achievement of patient-acceptable symptom state (PASS) thresholds for the mHHS and HOS-SSS. There was no significant difference between the 2 groups with regard to secondary procedures and complications.
Hip arthroscopy for the treatment of FAI and labral tears in patients with depression and/or anxiety resulted in significant intermediate-term improvements in functional and health-related quality-of-life scales. However, compared with a benchmark control group, the functional scores in this patient population started lower and ended lower. In addition, the patients in the depression/anxiety cohort had a lower rate of achieving PASS thresholds than those in the control group.
Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
抑郁和焦虑被认为是各种骨科手术干预中的不良预后因素。本研究的目的是报告髋关节镜检查治疗伴有抑郁和/或焦虑的患者的股骨髋臼撞击症(FAI)和盂唇撕裂的中期结果。
对2008年至2018年期间因FAI和盂唇撕裂接受初次髋关节镜检查且自我报告有抑郁和/或焦虑病史的患者的数据进行回顾性分析。纳入的患者至少有以下一项患者报告结局(PRO)评分:改良Harris髋关节评分(mHHS)、非关节炎髋关节评分(NAHS)、髋关节结局评分 - 运动特定子量表(HOS - SSS)、国际髋关节结局工具(iHOT - 12)、患者满意度评分、简短形式12项 - 精神健康量表(SF - M)、退伍军人兰德12项 - 精神健康量表(VR - M)以及疼痛视觉模拟量表(VAS),或在研究期间进行的翻修手术。患者按1:1的比例与无抑郁和/或焦虑的基准对照组进行倾向匹配,以控制混杂变量。分析还包括临床相关阈值、翻修手术和生存率。
本研究纳入了125例伴有抑郁和/或焦虑的患者的髋关节,并成功与125例无抑郁和/或焦虑的对照髋关节匹配。抑郁/焦虑组在所有功能结局评分上均有显著改善,改善程度与对照组相当。然而,抑郁/焦虑组在术前HOS - SSS、SF - M和VR - M评分显著较低;在中期mHHS、NAHS、HOS - SSS、SF - M和VR - M评分较低;并且在mHHS和HOS - SSS的患者可接受症状状态(PASS)阈值达成率较低。两组在二次手术和并发症方面无显著差异。
髋关节镜检查治疗伴有抑郁和/或焦虑的患者的FAI和盂唇撕裂在功能和健康相关生活质量量表方面中期有显著改善。然而,与基准对照组相比,该患者群体的功能评分开始时较低且结束时也较低。此外,抑郁/焦虑组患者达到PASS阈值的比率低于对照组。
预后III级。有关证据水平的完整描述,请参阅作者指南。